WHO Standard Material Transfer Agreement (SMTA 2), Pandemic Influenza Preparedness (PIP) Framework

Business model | Quality management

Annotations

This Standard Material Transfer Agreement 2 (SMTA 2) forms part of the WHO Pandemic Influenza Preparedness (PIP) Framework for the sharing of influenza viruses and access to vaccines and other benefits. The SMTA 2 is a form of agreement between the WHO and influenza product manufacturers, research institutions, or other entities (“Recipients“) that receive PIP Biological Materials from the WHO Global Influenza Surveillance and Response System (“GISRS“).

The template structure provides for Recipients to commit to at least two benefit sharing options based on their nature and capacities. The options include donation of products to WHO, reservation of products at an affordable price for WHO, and licensing and technology transfer to manufacturers in developing countries. The commitments made will be included in an Annex to be agreed between WHO and the Recipient. Recipients may only further transfer the materials with entities that have concluded SMTAs with WHO.

Details of signed agreements and benefits secured are available on the WHO website.

Provision Language

Article 4. Obligations of the Recipient

[…]

4.2 The Recipient shall ensure that the PIP biological materials are handled in accordance with applicable WHO guidelines and national bio-safety standards.

Download Full Agreement

Master Alliance Provisions Guide (MAPGuide)

WHO Standard Material Transfer Agreement (SMTA 2), Pandemic Influenza Preparedness (PIP) Framework

Provision Language

Contact Us

Get In Touch

Browse

Contact Us

Get In Touch

Browse

Sign Up to Our Newsletter

Master Alliance Provisions Guide (MAPGuide)

WHO Standard Material Transfer Agreement (SMTA 2), Pandemic Influenza Preparedness (PIP) Framework

Provision Language

Get In Touch

Browse

Title

Sign Up to Our Newsletter

Agreement Type

Select Partner Type

Select Development Stage

Select Technology

Select Issue or Sub-issues